Current Views on Type 2 Diabetes

Overview

Journal J Endocrinol

Specialty Endocrinology

Date 2009 Sep 23

PMID 19770178

Citations 142

Authors

Yi Lin

Zhongjie Sun

Affiliations

Soon will be listed here.

Abstract

Type 2 diabetes mellitus (T2DM) affects a large population worldwide. T2DM is a complex heterogeneous group of metabolic disorders including hyperglycemia and impaired insulin action and/or insulin secretion. T2DM causes dysfunctions in multiple organs or tissues. Current theories of T2DM include a defect in insulin-mediated glucose uptake in muscle, a dysfunction of the pancreatic beta-cells, a disruption of secretory function of adipocytes, and an impaired insulin action in liver. The etiology of human T2DM is multifactorial, with genetic background and physical inactivity as two critical components. The pathogenesis of T2DM is not fully understood. Animal models of T2DM have been proved to be useful to study the pathogenesis of, and to find a new therapy for, the disease. Although different animal models share similar characteristics, each mimics a specific aspect of genetic, endocrine, metabolic, and morphologic changes that occur in human T2DM. The purpose of this review is to provide the recent progress and current theories in T2DM and to summarize animal models for studying the pathogenesis of the disease.

Citing Articles

Incretin-based therapy: a new horizon in diabetes management.

Zarei M, Sahebi Vaighan N, Farjoo M, Talebi S, Zarei M J Diabetes Metab Disord. 2024; 23(2):1665-1686.

PMID: 39610543 PMC: 11599551. DOI: 10.1007/s40200-024-01479-3.

The post-translational modification O-GlcNAc is a sensor and regulator of metabolism.

Morales M, Pratt M Open Biol. 2024; 14(10):240209.

PMID: 39474868 PMC: 11523104. DOI: 10.1098/rsob.240209.

Targeting Hypoglycemic Natural Products from the Cloud Forest Plants Using Chemotaxonomic Computer-Assisted Selection.

Mayo-Montor C, Vidal-Limon A, Loyola-Vargas V, Carmona-Hernandez O, Barreda-Castillo J, Monribot-Villanueva J Int J Mol Sci. 2024; 25(20).

PMID: 39456663 PMC: 11507857. DOI: 10.3390/ijms252010881.

Insights to the emerging potential of glucokinase activators as antidiabetic agent.

Mehra A, Kumar S, Mittal A, Kohli R, Mittal A Pharm Pat Anal. 2024; 13(1-3):53-71.

PMID: 39316577 PMC: 11449038. DOI: 10.1080/20468954.2024.2389762.

Molecular Aspects in the Development of Type 2 Diabetes and Possible Preventive and Complementary Therapies.

Simon-Szabo L, Lizak B, Sturm G, Somogyi A, Takacs I, Nemeth Z Int J Mol Sci. 2024; 25(16).

PMID: 39201799 PMC: 11354764. DOI: 10.3390/ijms25169113.

References

Dong X, Park S, Lin X, Copps K, Yi X, White M . Irs1 and Irs2 signaling is essential for hepatic glucose homeostasis and systemic growth. J Clin Invest. 2005; 116(1):101-14. PMC: 1319221. DOI: 10.1172/JCI25735. View

Baudry A, Leroux L, Jackerott M, Joshi R . Genetic manipulation of insulin signaling, action and secretion in mice. Insights into glucose homeostasis and pathogenesis of type 2 diabetes. EMBO Rep. 2002; 3(4):323-8. PMC: 1084066. DOI: 10.1093/embo-reports/kvf078. View

Lowell B, Shulman G . Mitochondrial dysfunction and type 2 diabetes. Science. 2005; 307(5708):384-7. DOI: 10.1126/science.1104343. View

Withers D . Insulin receptor substrate proteins and neuroendocrine function. Biochem Soc Trans. 2001; 29(Pt 4):525-9. DOI: 10.1042/bst0290525. View

Lazar M . How obesity causes diabetes: not a tall tale. Science. 2005; 307(5708):373-5. DOI: 10.1126/science.1104342. View

Gimeno R, Klaman L . Adipose tissue as an active endocrine organ: recent advances. Curr Opin Pharmacol. 2005; 5(2):122-8. DOI: 10.1016/j.coph.2005.01.006. View

Lin X, Taguchi A, Park S, Kushner J, Li F, Li Y . Dysregulation of insulin receptor substrate 2 in beta cells and brain causes obesity and diabetes. J Clin Invest. 2004; 114(7):908-16. PMC: 518668. DOI: 10.1172/JCI22217. View

Bandyopadhyay D, Kusari A, Kenner K, Liu F, Chernoff J, Gustafson T . Protein-tyrosine phosphatase 1B complexes with the insulin receptor in vivo and is tyrosine-phosphorylated in the presence of insulin. J Biol Chem. 1997; 272(3):1639-45. DOI: 10.1074/jbc.272.3.1639. View

Stumvoll M, Goldstein B, van Haeften T . Type 2 diabetes: principles of pathogenesis and therapy. Lancet. 2005; 365(9467):1333-46. DOI: 10.1016/S0140-6736(05)61032-X. View

10.

Venables M, Jeukendrup A . Physical inactivity and obesity: links with insulin resistance and type 2 diabetes mellitus. Diabetes Metab Res Rev. 2009; 25 Suppl 1:S18-23. DOI: 10.1002/dmrr.983. View

11.

Taniguchi C, Ueki K, Kahn R . Complementary roles of IRS-1 and IRS-2 in the hepatic regulation of metabolism. J Clin Invest. 2005; 115(3):718-27. PMC: 548317. DOI: 10.1172/JCI23187. View

12.

Ridderstrale M, Groop L . Genetic dissection of type 2 diabetes. Mol Cell Endocrinol. 2008; 297(1-2):10-7. DOI: 10.1016/j.mce.2008.10.002. View

13.

Louvi A, Accili D, Efstratiadis A . Growth-promoting interaction of IGF-II with the insulin receptor during mouse embryonic development. Dev Biol. 1997; 189(1):33-48. DOI: 10.1006/dbio.1997.8666. View

14.

Hotamisligil G, Peraldi P, Budavari A, Ellis R, White M, Spiegelman B . IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance. Science. 1996; 271(5249):665-8. DOI: 10.1126/science.271.5249.665. View

15.

Jahn R, Scheller R . SNAREs--engines for membrane fusion. Nat Rev Mol Cell Biol. 2006; 7(9):631-43. DOI: 10.1038/nrm2002. View

16.

McNew J, Parlati F, Fukuda R, Johnston R, Paz K, Paumet F . Compartmental specificity of cellular membrane fusion encoded in SNARE proteins. Nature. 2000; 407(6801):153-9. DOI: 10.1038/35025000. View

17.

Ren J, Marshall B, Gulve E, Gao J, Johnson D, Holloszy J . Evidence from transgenic mice that glucose transport is rate-limiting for glycogen deposition and glycolysis in skeletal muscle. J Biol Chem. 1993; 268(22):16113-5. View

18.

Thyfault J, Cree M, Zheng D, Zwetsloot J, Tapscott E, Koves T . Contraction of insulin-resistant muscle normalizes insulin action in association with increased mitochondrial activity and fatty acid catabolism. Am J Physiol Cell Physiol. 2006; 292(2):C729-39. DOI: 10.1152/ajpcell.00311.2006. View

19.

Zimmet P, Alberti K, Shaw J . Global and societal implications of the diabetes epidemic. Nature. 2001; 414(6865):782-7. DOI: 10.1038/414782a. View

20.

Fisher S, Kahn C . Insulin signaling is required for insulin's direct and indirect action on hepatic glucose production. J Clin Invest. 2003; 111(4):463-8. PMC: 151923. DOI: 10.1172/JCI16426. View